Abstract
Monitoring of multiple sclerosis (MS) requires additional molecular markers. Recently, we used original TCA-precipitation/extraction approach in combination with MALDI TOF/TOF mass-spectrometry and identified earlier unknown 48 kDa form of the unconventional myosin IC isoform b (Myo1C) in blood serum of the MS patients. Further examination of TCA-extracted fraction of blood serum of these patients by means of thin-layer chromatography and HPLC gel-filtration allowed detecting 300-500 Da peptides. MALDI TOF/TOF massspectrometry of these peptides showed that they contain Ser-Pro-Cys amino acid sequence. We discussed potential mechanisms of a release of these peptides that were earlier unknown in blood serum of the MS patients.
Keywords: Multiple sclerosis, blood serum, peptides.
Protein & Peptide Letters
Title:Identification of SER-PRO-CYS Peptide in Blood Serum of Multiple Sclerosis Patients
Volume: 23 Issue: 9
Author(s): Severyn Myronovkij, Nazar Negrych, Tetyana Nehrych, Volodymyr Tkachenko, Serhiy Souchelnytskyi, Rostyslav Stoika and Yuriy Kit
Affiliation:
Keywords: Multiple sclerosis, blood serum, peptides.
Abstract: Monitoring of multiple sclerosis (MS) requires additional molecular markers. Recently, we used original TCA-precipitation/extraction approach in combination with MALDI TOF/TOF mass-spectrometry and identified earlier unknown 48 kDa form of the unconventional myosin IC isoform b (Myo1C) in blood serum of the MS patients. Further examination of TCA-extracted fraction of blood serum of these patients by means of thin-layer chromatography and HPLC gel-filtration allowed detecting 300-500 Da peptides. MALDI TOF/TOF massspectrometry of these peptides showed that they contain Ser-Pro-Cys amino acid sequence. We discussed potential mechanisms of a release of these peptides that were earlier unknown in blood serum of the MS patients.
Export Options
About this article
Cite this article as:
Myronovkij Severyn, Negrych Nazar, Nehrych Tetyana, Tkachenko Volodymyr, Souchelnytskyi Serhiy, Stoika Rostyslav and Kit Yuriy, Identification of SER-PRO-CYS Peptide in Blood Serum of Multiple Sclerosis Patients, Protein & Peptide Letters 2016; 23 (9) . https://dx.doi.org/10.2174/0929866523666160622215628
DOI https://dx.doi.org/10.2174/0929866523666160622215628 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reproductive Toxicology of Environmental Toxicants: Emerging Issues and Concerns
Current Pharmaceutical Design Evaluation on Auto-segmentation of the Clinical Target Volume (CTV) for Graves' Ophthalmopathy (GO) with a Fully Convolutional Network (FCN) on CT Images
Current Medical Imaging Improving Nutritional Quality of Plant Proteins Through Genetic Engineering
Current Genomics 3D-QSAR Studies on Flavone-8-acetic Acid Derivatives of Aminopeptidase N Inhibitors
Medicinal Chemistry Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19
Current Molecular Pharmacology Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes
Current Genomics Predicting the Types of Plant Heat Shock Proteins
Letters in Organic Chemistry Advances in Antioxidant Potential of Natural Alkaloids
Current Bioactive Compounds Design, Synthesis and Characterization of N', N'-Diaryl Ureas as p38 Kinase Inhibitors
Medicinal Chemistry Optimization of Countercurrent Supercritical Fluid Extraction of Minor Components from Olive Oil
Current Analytical Chemistry Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Lipid-Drug Conjugates for Oral Bioavailability Enhancement
Recent Patents on Nanomedicine The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
Medicinal Chemistry Fabrication of Multi-functionalized Gold Nanoparticles and the Application to Electrochemical Detection of Nitrite
Current Nanoscience Recent Advances in Physical Approaches for Transdermal Penetration Enhancement
Current Drug Therapy New Synthesis of Isoindolo[2,1–b]isoquinolines. Preparation and Aqueous Bioavailability of its Silica Nanoparticles Hybrid System
Current Organic Chemistry Efficacy and Toxicological Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety